UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic

Journal of Virology, 2011-07, Vol.85 (14), p.7236-7245

2011

Link zum Volltext

Verfügbarkeit prüfen

Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies

Journal of Virology, 2011-07, Vol.85 (14), p.6986-6995

2011

Link zum Volltext

Verfügbarkeit prüfen

Susceptibility of Recently Transmitted Subtype B Human Immunodeficiency Virus Type 1 Variants to Broadly Neutralizing Antibodies

Journal of Virology, 2007-08, Vol.81 (16), p.8533-8542

2007

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals

PloS one, 2013-01, Vol.8 (1), p.e54684-e54684

2013

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course

PloS one, 2011-07, Vol.6 (7), p.e22208-e22208

2011

Link zum Volltext

Verfügbarkeit prüfen

The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype

AIDS research and human retroviruses, 2016-11, Vol.32 (10-11), p.1135

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression

AIDS (London), 2020-07, Vol.34 (9), p.1303-1312

2020

Link zum Volltext

Verfügbarkeit prüfen

Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

Nature medicine, 2010-09, Vol.16 (9), p.995

2010

Link zum Volltext

Verfügbarkeit prüfen

The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor–recipient pair

Virology (New York, N.Y.), 2012-01, Vol.422 (1), p.70-80

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity

Retrovirology, 2013-09, Vol.10 (1), p.102-102, Article 102

2013

Link zum Volltext

Verfügbarkeit prüfen

Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers

AIDS (London), 2014-05, Vol.28 (8), p.1237-1240

2014

Link zum Volltext

Verfügbarkeit prüfen

Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies

AIDS (London), 2016-09, Vol.30 (14), p.2179-2184

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds

Retrovirology, 2016-07, Vol.13 (1), p.48-48, Article 48

2016

Link zum Volltext

Verfügbarkeit prüfen

Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control

AIDS (London), 2011-11, Vol.25 (18), p.2217-2226

2011

Link zum Volltext

Verfügbarkeit prüfen

Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro

Virology (New York, N.Y.), 2007-07, Vol.363 (2), p.447-453

2007

Link zum Volltext

Verfügbarkeit prüfen

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates

Virology (New York, N.Y.), 2007-03, Vol.359 (1), p.92-104

2007

Link zum Volltext

Verfügbarkeit prüfen

Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection

AIDS (London), 2009-01, Vol.23 (1), p.19-28

2009

Link zum Volltext

Verfügbarkeit prüfen

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

Cell reports. Medicine, 2022-01, Vol.3 (1), p.100486-100486, Article 100486

2022

Link zum Volltext

Verfügbarkeit prüfen

Decreasing Sensitivity to RANTES (Regulated on Activation, Normally T Cell–Expressed and –Secreted) Neutralization of CC Chemokine Receptor 5–Using, Non–Syncytium-Inducing Virus Variants in the Course of Human Immunodeficiency Virus Type 1 Infection

The Journal of infectious diseases, 2003-09, Vol.188 (6), p.864-872

2003

Link zum Volltext

Verfügbarkeit prüfen

Increased Neutralization Sensitivity of Recently Emerged CXCR4-Using Human Immunodeficiency Virus Type 1 Strains Compared to Coexisting CCR5-Using Variants from the Same Patient

Journal of Virology, 2007-01, Vol.81 (2), p.525-531

2007

Link zum Volltext

Verfügbarkeit prüfen

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

AIDS (London), 2011-09, Vol.25 (14), p.1691-1700

2011

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists

Journal of Virology, 2004-03, Vol.78 (6), p.2722-2728

2004

Link zum Volltext

Verfügbarkeit prüfen

Cytopathic Effects of Non-Syncytium-Inducing and Syncytium-Inducing Human Immunodeficiency Virus Type 1 Variants on Different CD4+-T-Cell Subsets Are Determined Only by Coreceptor Expression

Journal of Virology, 2001-11, Vol.75 (21), p.10455-10459

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Humans
(27)
Life Sciences & Biomedicine
(26)
Virology
(23)
Immunology
(18)
Infectious Diseases
(17)
Human Immunodeficiency Virus 1
(15)
Male
(15)
Hiv-1 - Immunology
(14)
Biological And Medical Sciences
(11)
Hiv Antibodies - Immunology
(11)
Hiv Infections - Virology
(11)
Hiv-1 - Genetics
(11)
Hiv Infections - Immunology
(10)
Hiv-1
(10)
Aids/hiv
(9)
Antibodies, Neutralizing - Immunology
(9)
Disease Progression
(9)
Hiv
(8)
Human Viral Diseases
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(10)
Journal Of Virology
(6)
Virology
(3)
Plos One
(2)
Retrovirology
(2)
Aids Research And Human Retroviruses
(1)
Cell Reports. Medicine
(1)
Nature Medicine
(1)
Plos Pathogens
(1)
The Journal Of Infectious Diseases
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic

Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies

Susceptibility of Recently Transmitted Subtype B Human Immunodeficiency Virus Type 1 Variants to Broadly Neutralizing Antibodies

Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals

Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course

The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype

Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression

Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor–recipient pair

Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity

Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers

Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds

Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control

Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates

Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

Decreasing Sensitivity to RANTES (Regulated on Activation, Normally T Cell–Expressed and –Secreted) Neutralization of CC Chemokine Receptor 5–Using, Non–Syncytium-Inducing Virus Variants in the Course of Human Immunodeficiency Virus Type 1 Infection

Increased Neutralization Sensitivity of Recently Emerged CXCR4-Using Human Immunodeficiency Virus Type 1 Strains Compared to Coexisting CCR5-Using Variants from the Same Patient

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists

Cytopathic Effects of Non-Syncytium-Inducing and Syncytium-Inducing Human Immunodeficiency Virus Type 1 Variants on Different CD4+-T-Cell Subsets Are Determined Only by Coreceptor Expression

Suchergebnisse filtern